CCR3 antagonists (Banyu)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCCR3 antagonists (Banyu)
Drug Alias NameCCR3 antagonists (Merck & Co)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 3 antagonists
TargetsC-C chemokine receptor type 3
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMsd Kk
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMsd Kk
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A